TGA sets out areas of reform focus but insists it has ‘no preconceived ideas’

The health regulator has insisted it has “no preconceived ideas” of what fresh regulations it may impose on the medicinal cannabis industry and said any reform that does occur will be “proportionate to the level of risk posed by the product”.

Michael Wiseman, assistant secretary of the Therapeutic Goods Administration’s International Regulatory Branch, told the ACannabis conference that the eight-week consultation that began on Monday was just that, a “genuine consultation”.